IMPORTANT FRAUD NOTICE FOR JOB SEEKERS It has come to our attention that fraudsters have been posing as Alterome Therapeutics’ employees and contacting job-seeking candidates regarding potential job opportunities with our company. These fraudulent messages sometimes include a digital check and request for confidential personal information. We will only post our open positions on our website and official Alterome Therapeutics, Inc company LinkedIn page. Only people with our official corporate email addresses will request information. Please note that Alterome’s recruiting process does not include asking candidates for banking information or other highly confidential information. If you are approached by someone who is pretending to be employed with Alterome in this manner, please end your contact with them immediately. We take this matter very seriously and do not want to see anyone be the victim of fraud or identity theft.
关于我们
Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with expertise in multiple areas of science and operations, dedicated to co-elevating toward our vision to bring life-changing and life-saving therapies to cancer patients. We believe in our journey, in each other, and in our ability to collaboratively develop therapies that will help end cancers. Thus, we seek the best people for our company and provide the resources they need to grow, develop, and accomplish our collective goals. We are moving forward with humility & empathy, fearlessness & resilience, with a sense of inclusion & belonging, open communication and a deep trust. And…we manage to have a lot of fun along the way!
- 网站
-
https://www.alterome.com
Alterome Therapeutics, Inc的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- San Diego，California
- 类型
- 私人持股
- 创立
- 2021
地点
-
主要
获取路线
13480 Evening Creek Dr N
450
US，California，San Diego，92128
Alterome Therapeutics, Inc员工
动态
-
We are grateful for the opportunity to help Home Start Inc. provide much needed school supplies to students in San Diego County. Together with Life Science Cares San Diego, it is our honor to support the community in the education of the next generation of thinkers.
Amazed, astounded, speechless, blown-away, astonished - whichever word you want to choose we are it! ?? 1500 backpacks and school supplies for San Diego County students, and we couldn't have done it with out YOU.??This mean every Home Start client starts the school year with a new backpack and fresh set of supplies, AND our programs have enough to fulfill the educational needs of clients all year long. ??Thank you to our corporate donors and partners: ??The Tony Robbins Foundation ??Willis Allen Real Estate ??Baker Tilly US ??Life Science Cares San Diego ??Alterome Therapeutics, Inc ??American Assets Trust, Inc. ??Aspen Neuroscience, Inc. ??CoStar Group ??JB Pacific ??Karen D Woods and Associates ??Longboard Pharmaceuticals ??Law Offices of Richard R. Roy, APC ??Scripps Assist ??SD Psychiatric Hospital ??Sony Electronics
-
-
-
-
-
+1
-
-
We are thrilled to announce #FDA clearance of #IND application for ALTA2618, the first mutant-selective targeted therapy for patients with AKT1 E17K-mutant solid tumors. We expect to initiate our Phase 1/1b study, AKTive001, in Q3 2024. This is an important milestone in Alterome’s mission to deliver the next generation of precision therapies and give hope to individuals affected by cancer.
-
-
Alterome Therapeutics would like to celebrate Patty Quintana on #AdminProfessionalsDay. We are extremely grateful to Patty for taking care of the entire team. Her dedication and enthusiasm keeps everything running smoothly.
-
-
At #AACR24 today, Alterome is presenting preclinical data supporting the development of our AKT1 E17K mutation-selective inhibitor, ALTA-2618. Full press release: https://bwnews.pr/49rQpsG
-
-
Thank you BiotechTV and Brian Orelli, PhD for stopping by the Alterome office in San Diego yesterday to discuss our Series B raise as well as our target disclosure.
?????????????? ????????: San Diego's Alterome Therapeutics, Inc raised a $132M Series B today for its precision oncology platform, including for programs targeting AKT1 E17K and KRAS. Co-Founder and CEO Eric Murphy describes what it was like raising the money in this environment Full video: https://lnkd.in/gZ4DV5Xf BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
Exciting times ahead!
We’re excited to announce the closing of our successful $132 million Series B financing that will support the advancement of our two next-generation #precisiononcology programs into clinical development. Full press release: https://lnkd.in/er9K8p6D
-
-
We’re excited to announce the closing of our successful $132 million Series B financing that will support the advancement of our two next-generation #precisiononcology programs into clinical development. Full press release: https://lnkd.in/er9K8p6D
-
-
On this International Women’s Day, we’d like to commemorate the remarkable achievements of women globally and express our heartfelt appreciation for the phenomenal women who play a pivotal role in our daily triumphs. At Alterome, we strive to create a culture that ensures every woman's voice is heard, valued, and empowered! We’d like to take a moment to convey our genuine gratitude and admiration for the amazing women whose unwavering efforts drive our company’s success. Your dedication, expertise, and leadership are essential. We celebrate your accomplishments today and every day. #internationalwomensday2024 #inspireinclusion #equality #womenempowerment
-
-
It’s #EmployeeAppreciationDay, and we are celebrating our amazing Alterhomies! Our team is a diverse group of dedicated individuals whose strong commitment to our mission is our greatest strength. We appreciate you! We've moved offices! The Alterome team is excited to continue our work in discovering life-changing therapies and inspiring hope for cancer patients.
-